Covid-19 Vaccines: The Need of the Hour
Keywords:
Vaccines, Covid19, SARS Cov2, Pandemic, Antigen, Efficacy, Immunity.Abstract
Coronavirus has invaded the whole world despite all necessary precautions. Several strategies and restrictions have been imposed to overcome the disease since the outbreak of covid19. To tackle this epidemic, getting vaccinated is the only effective way. Several vaccine types have been tested for covid19, including nucleic acid-based, protein-based, and whole virus-based vaccines. The clinical trial phase of several vaccines is underway, however; twenty vaccines have been used on a wide scale throughout the world, out of which six vaccines are granted in India. The current article is mainly focused on vaccines approved for use, their trials, and efficacy, and how they have been used during the pandemic to shed light on disease control.
Downloads
References
Ascarateil, S., & Dupuis, L. (2006). Surfactants in vaccine adjuvants: description and perspectives. Vaccine, 24, S83–S85. https://doi.org/10.1016/j.vaccine.2005.01.134
Astrazeneca. (2021). After your COVID-19 vaccination.
Bharat Biotech Covid-. (2021). Fact sheet for vaccine recipients & caregivers restricted to use in an emergency situation of covid-19 sars-cov-2 vaccine by Bharat biotech. 500
Bharat Biotech. (2021). Clinical Research. https://www.bharatbiotech.com/
Bhardwaj, S. (2021). Single-dose Sputnik Light could be the first single-dose vaccine launched in India. 1–2.
Blankestijn, P. J., & Meijvis, S. C. (2020). Ensuring global access to COVID-19 vaccines. 6736(20), 10–11. https://doi.org/10.1016/S0140-6736(20)30763-7
Bralić, I. (2018). Vaccines: the past, present, and future. Pediatric Medicine, AB011. https://doi.org/10.21037/pm.2018
CDC. (2020). Adjuvants and Vaccines. https://www.cdc.gov/vaccinesafety/concerns/adjuvants.html
ClinicalTrials.gov. (2020). Convalescent Plasma Therapy for COVID-19 Patients. https://clinicaltrials.gov/ct2/show/NCT04565197
Covid 19 Vaccine Tracker. (2021). vaccine candidates. https://covid19.trackvaccines.org/vaccines/
Delany, I., Rappuoli, R., & De Gregorio, E. (2014). Vaccines for the 21st century. EMBO Molecular Medicine, 6(6), 708–720. https://doi.org/10.1002/emmm.201403876
Dr. Reddy’s. (2021). SUMMARY OF PRODUCT CHARACTERISTICS (Sputnik V). 283.
Fauci, A. S. (2021). The story behind COVID-19 vaccines. Science, 372(6538), 109. https://doi.org/10.1126/science.abi8397
Gaon Connection. (2021). Explained: Why Covaxin is not approved by WHO? Why USFDA rejected its emergency use? Will it affect international travel? https://en.gaonconnection.com/covaxin-explained-bharat-biotech-efficacy-approval-united-states-who-world-health-organisation-covishield-covid19-coronavirus/
Gogolishvili, D., Lead, S. (2021). COVID-19 VACCINES. International Federation of Pharmaceutical Manufacturers & Associations. (2014). The Steps Behind Developing a New Vaccine. IFPMA Resources. https://www.ifpma.org/wp-content/uploads/2019/07
Johnson & Johnson, V. (2021). Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine (Johnson & Johnson). 7–9.
Levine, M. M., & Sztein, M. B. (2004). Vaccine development strategies for improving immunization : the role of modern immunology. 5(5), 460–464.
Mayhew, S. (2020). The COVID-19 vaccine development landscape. Nature Reviews. Drug Discovery, 19(5), 305–306. https://doi.org/10.1038/d41573-020-00073-5
Mediline Plus (2021).Remdesivir Injection. https://medlineplus.gov/druginfo/meds/a620033.html
Ministry of health and family welfare, G. of I. (2021). About the Vaccines. https://www.mohfw.gov.in/covid_vaccination/vaccination/faqs.html
Poland, G. A., I. G., & Kennedy, R. B. (2020). Review SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. The Lancet, 396(10262), 1595–1606. https://doi.org/10.1016/S0140-6736(20)32137-1
Prevention, C. of D. C. and. (2021). Immunization: The Basics. https://www.cdc.gov/vaccines/vac-gen/imz-basics.html
Punt, Stranford, Jones, & Owen. (2019). Immunology (Eight).
REUTER. (2021). India gives emergency approval for world’s first COVID-19 DNA vaccine. https://www.reuters.com/business/healthcare-pharmaceuticals/india-approves-zydus-cadilas-covid-19-vaccine-emergency-use-2021-08-20/
REUTERS. (2021). India approves J&J vaccine; no delivery timeline yet. https://www.reuters.com/world/india/india-approves-jj-covid-19-vaccine-emergency-use-2021-08-07/
Rico-Mesa, J. S., Rosas, D., Ahmadian-Tehrani, A., White, A., Anderson, A. S., & Chilton, R. (2020). The Role of Anticoagulation in COVID-19-Induced Hypercoagulability. Current Cardiology Reports, 22(7), 53. https://doi.org/10.1007/s11886-020-01328-8
Serum Institute of India. (2021). ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) COVISHIELD In Prevention Of COVID-19 In Individuals 18 Years Of Age And Older. Vaccine Fact Sheet, 0–1.
Services, (2021). Vaccines types. https://www.hhs.gov/immunization/basics/types/index.html
Shah, S. (2021). COVID-19 PANDEMIC AND VACCINE. 21–23.
Thanh Le, T., Andreadakis, Z., Kumar, A., Gómez Román, R., Tollefsen, S., Saville, M. (FDA)., U. S. F. and D. A. (2020). Fact Sheet for Recipients and Caregivers Emergency-Moderna. 2019
UNICEF. (2021). What you need to know about COVID-19 vaccines. https://www.unicef.org/coronavirus/what-you-need-to-know-covid-vaccine
S. A. C. O. V. (2021). Overview of Janssen’ s Single-Dose. 1–54.
Ventures, N. (2021). New study provides comparative analysis of twelve covid19 vaccines. 18–20.
WHO. (2020). Coronavirus disease (COVID-19): Dexamethasone. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19-dexamethasone
WHO. (2020). How are Vaccines Developed? https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed
WHO. (2021). Comirnaty, INN-Covid-19 mRNA Vaccine BioNTech. 1–22.
WHO. (2021). WHO Coronavirus Dashboard. https://covid19.who.int/
World Health Organisation. (2021). Types of Vaccines. https://www.who.int/news-room/q
Worldometer. (2021). Coronavirus cases and deaths. https://www.worldometers.info/coronavirus/
Yan, Z., & Yang, M. (2021). COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Sapkota MD, Sandeep Sangle, Ghuge A.D., Gaiki S.G., Mogle U.P.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If the material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/
